BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36966872)

  • 1. Cognitive Functioning in Survivors of Hematopoietic Stem Cell Transplantation Compared With a Matched General Population Sample-The Maastricht Observational Study of Late Effects After Stem Cell trAnsplantation Study.
    Wauben B; van der Poel MWM; Greevenbroek MMJ; van Yperen NC; Schram MT; van Boxtel MPJ; Sastry M; Simons SO; Stehouwer CDA; Dagnelie PC; Wesselius A; Schouten HC; Köhler S
    Transplant Cell Ther; 2023 Jul; 29(7):468.e1-468.e8. PubMed ID: 36966872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term neurocognitive and quality of life outcomes in survivors of pediatric hematopoietic cell transplant.
    Wu NL; Krull KR; Cushing-Haugen KL; Ullrich NJ; Kadan-Lottick NS; Lee SJ; Chow EJ
    J Cancer Surviv; 2022 Jun; 16(3):696-704. PubMed ID: 34086185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal Study.
    Sharafeldin N; Bosworth A; Patel SK; Chen Y; Morse E; Mather M; Sun C; Francisco L; Forman SJ; Wong FL; Bhatia S
    J Clin Oncol; 2018 Feb; 36(5):463-475. PubMed ID: 29252122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive functioning in long-term survivors of pediatric hematopoietic cell transplantation.
    Parris KR; Russell KM; Triplett BM; Phipps S
    Bone Marrow Transplant; 2021 Apr; 56(4):873-882. PubMed ID: 33190144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant.
    Wu NL; Phipps AI; Krull KR; Syrjala KL; Carpenter PA; Connelly-Smith LS; Flowers ME; Krakow EF; Ueda Oshima M; Lee SJ; Chow EJ
    Blood Adv; 2022 Jul; 6(14):4347-4356. PubMed ID: 35584396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study.
    Arora M; Sun CL; Ness KK; Teh JB; Wu J; Francisco L; Armenian SH; Schad A; Namdar G; Bosworth A; Kuo L; Weisdorf DJ; Forman SJ; Bhatia S
    JAMA Oncol; 2016 Oct; 2(10):1277-1286. PubMed ID: 27254472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing long-term effects after stem cell transplantation: design of the MOSA study.
    Wauben B; van Yperen NC; van der Poel MWM; Köhler S; van Greevenbroek MMJ; Schouten HC
    J Clin Epidemiol; 2022 Aug; 148():10-16. PubMed ID: 35346784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.
    Syrjala KL; Artherholt SB; Kurland BF; Langer SL; Roth-Roemer S; Elrod JB; Dikmen S
    J Clin Oncol; 2011 Jun; 29(17):2397-404. PubMed ID: 21537032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies.
    Ullrich CK; Baker KK; Carpenter PA; Flowers ME; Gooley T; Stevens S; Krakow EF; Oshima MU; Salit RB; Vo P; Connelly-Smith L; Lee SJ; Wood WA
    Transplant Cell Ther; 2023 Mar; 29(3):200.e1-200.e8. PubMed ID: 36494015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation.
    Smith PJ; Lew M; Lowder Y; Romero K; Thompson JC; Bohannon L; Pittman A; Artica A; Ramalingam S; Choi T; Gasparetto C; Horwitz M; Long G; Lopez R; Rizzieri D; Sarantopoulos S; Sullivan K; Chao N; Sung AD
    Bone Marrow Transplant; 2022 Jan; 57(1):89-94. PubMed ID: 34667271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive functioning of older adults prior to hematopoietic stem cell transplantation.
    Lacy M; Fong M; Bolton C; Maranzano M; Bishop M; Artz A
    Bone Marrow Transplant; 2021 Oct; 56(10):2575-2581. PubMed ID: 34031555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation.
    Mayo SJ; Messner HA; Rourke SB; Howell D; Victor JC; Lipton JH; Kuruvilla J; Gutpa V; Kim DDH; Michelis FV; Metcalfe K
    Bone Marrow Transplant; 2020 May; 55(5):918-928. PubMed ID: 31745248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors.
    Wu NL; Hingorani S; Cushing-Haugen KL; Lee SJ; Chow EJ
    Transplant Cell Ther; 2021 May; 27(5):434.e1-434.e6. PubMed ID: 33775588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation.
    Mayo S; Messner HA; Rourke SB; Howell D; Victor JC; Kuruvilla J; Lipton JH; Gupta V; Kim DD; Piescic C; Breen D; Lambie A; Loach D; Michelis FV; Alam N; Uhm J; McGillis L; Metcalfe K
    Bone Marrow Transplant; 2016 Jun; 51(6):841-7. PubMed ID: 26926230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study.
    Scherwath A; Schirmer L; Kruse M; Ernst G; Eder M; Dinkel A; Kunze S; Balck F; Bornhäuser M; Ehninger G; Dolan K; Gramatzki M; Kolb HJ; Heußner P; Wilhelm H; Beelen DW; Schulz-Kindermann F; Zander AR; Koch U; Mehnert A
    Psychooncology; 2013 Jul; 22(7):1509-16. PubMed ID: 22945857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study.
    Ness KK; Bhatia S; Baker KS; Francisco L; Carter A; Forman SJ; Robison LL; Rosenthal J; Gurney JG
    Arch Pediatr Adolesc Med; 2005 Aug; 159(8):706-13. PubMed ID: 16061776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
    Fulcher J; Blanchard AP; Bredeson C; van Walraven C
    Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.
    Kelly DL; Buchbinder D; Duarte RF; Auletta JJ; Bhatt N; Byrne M; DeFilipp Z; Gabriel M; Mahindra A; Norkin M; Schoemans H; Shah AJ; Ahmed I; Atsuta Y; Basak GW; Beattie S; Bhella S; Bredeson C; Bunin N; Dalal J; Daly A; Gajewski J; Gale RP; Galvin J; Hamadani M; Hayashi RJ; Adekola K; Law J; Lee CJ; Liesveld J; Malone AK; Nagler A; Naik S; Nishihori T; Parsons SK; Scherwath A; Schofield HL; Soiffer R; Szer J; Twist I; Warwick A; Wirk BM; Yi J; Battiwalla M; Flowers ME; Savani B; Shaw BE
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):228-241. PubMed ID: 28939455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is age a risk factor for cognitive changes following hematopoietic cell transplantation?
    Stratton J; Sylvia A; Hoodin F; Choi SW; Pawarode A; Giordani B; Votruba K
    Bone Marrow Transplant; 2021 Mar; 56(3):567-569. PubMed ID: 32862198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.